Pharma channel feed

In sur­prise, FDA ap­proves Uro­Gen's chemo-turned-gel drug af­ter neg­a­tive ad­comm vote

44 minutes ago
FDA+

Ex­clu­sive: Kennedy picks for vac­cine ad­vi­so­ry board were paid ex­perts against Mer­ck in civ­il cas­es

2 hours ago
R&D
FDA+

RFK Jr. names eight new ACIP mem­bers, in­clud­ing pop­u­lar vac­cine crit­ic Robert Mal­one

18 hours ago
FDA+

Trump of­fi­cials seek price de­tails and weigh con­sumer sales as they ex­am­ine most fa­vored na­tion plan

22 hours ago

Trump’s HHS urges against re­viv­ing Cham­ber of Com­merce’s IRA law­suit

22 hours ago
Law

Fed­er­al of­fi­cials sched­ule three lis­ten­ing ses­sions this sum­mer to ad­dress drug com­pe­ti­tion

22 hours ago

Nu­va­tion Bio scores first FDA ap­proval for new lung can­cer drug

Yesterday
FDA+

Have sky-high sales pro­jec­tions set the obe­si­ty mar­ket up to fail?

Yesterday
In Focus

Ver­tex lays off 125 work­ers af­ter type 1 di­a­betes cell ther­a­py failed study in March

Yesterday
People
Cell/Gene Tx

Ar­genx says its drug Vyv­gart looks promis­ing in two more au­toim­mune dis­eases

Yesterday
R&D

FDA’s Makary says he wasn’t part of de­ci­sion to gut ACIP, de­fers pos­si­ble VRB­PAC changes to Prasad

Yesterday
R&D
FDA+

GoodRx goes toe-to-toe with Hims, Ro as it push­es in­to ED treat­ment

2 days ago
Health Tech

Up­dat­ed: HHS chief Kennedy re­moves all ACIP mem­bers, dis­man­tling vac­cine board

2 days ago
FDA+

FDA adds bio­mark­er lim­its to stom­ach, esophageal can­cer la­bels for Mer­ck­'s Keytru­da and BM­S' Op­di­vo

2 days ago
FDA+

Up­dat­ed: Mer­ck wins FDA ap­proval for RSV an­ti­body drug, mak­ing a hot mar­ket more com­pet­i­tive

3 days ago
R&D
FDA+

In a break from oth­er biotechs, Twist Bio­science throws sup­port be­hind tar­iffs on syn­thet­ic DNA

3 days ago
Manufacturing

Sanofi leans in­to 'first-mover ad­van­tage' by ship­ping Bey­for­tus ear­ly, as RSV an­ti­body mar­ket set to heat up

3 days ago
Manufacturing

EMA con­sid­ers se­ri­ous eye con­di­tion a ‘very rare’ side ef­fect of semaglu­tide 

5 days ago
FDA+

Phar­ma im­ports in­to the US re­turn to nor­mal af­ter March tar­iff stock­pil­ing

6 days ago
Manufacturing

Biotech ranks as Chi­na’s best shot to sur­pass US in emerg­ing tech, re­port finds

6 days ago
China

A decade af­ter its ill-fat­ed $40.5B megadeal, Te­va piv­ots from gener­ics to in­no­va­tion

Last week
R&D

Anne Wo­j­ci­c­ki and Re­gen­eron set to duke it out in restart­ed 23andMe auc­tion

Last week
Deals

Ex­clu­sive: Af­ter cut­ting most staff, Cas­ma eyes path to clin­ic with its first au­tophagy-boost­ing drug

Last week
R&D

Ex-HHS work­ers ac­cuse Trump ad­min­is­tra­tion of us­ing flawed da­ta to is­sue fir­ings

Last week
People
Law
1234 Next page Last page
A service from the Financial Times